Momentum Stocks: Hemispherx Biopharma, Inc. (NYSEMKT:HEB), Hertz Global Holdings, Inc. (NYSE:HTZ), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Headwaters Incorporated (NYSE:HW), Ambac Financial Group (NASDAQ:AMBC)

Hemispherx Biopharma, Inc. (NYSEMKT:HEB) belongs to Healthcare sector. Its weekly performance is -3.00%. On last trading day company shares ended up $0.19. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) distance from 50-day simple moving average (SMA50) is -16.45%. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) on June 25, 2015, declared that it received formal notice on June 18, 2015, that the European Patent Office’s Examining Division issued the formal notification of intention to grant the Hemispherx application titled “Double-Stranded Ribonucleic Acids with Rugged Physiochemical Structure and Highly Specific Biologic Activity” by inventors Carter, et al. and assignee Hemispherx Biopharma, Inc.

Hertz Global Holdings, Inc. (NYSE:HTZ) shares advanced 0.30% in last trading session and ended the day at $16.87. HTZ Gross Margin is 46.90% and its return on assets is 2.80%. Hertz Global Holdings, Inc. (NYSE:HTZ) quarterly performance is -17.95%. On 2 Ju;y, The Hertz Corporation (NYSE:HTZ) has said that despite lengthy discussions regarding a contractual dispute it regrets that it had to end its car hire agreement with Ryanair. Hertz reassures customers that existing bookings will be fully honored and that future bookings can be made directly at the Hertz, Thrifty and Firefly websites.

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is 0.13%. On last trading day company shares ended up $7.92. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is -9.43%. On 1 July, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) declared long-term follow up from its pivotal Phase 2 trial of Iclusig® (ponatinib), its approved BCR-ABL inhibitor, in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Headwaters Incorporated (NYSE:HW) ended the last trading day at $18.52. Company weekly volatility is calculated as 3.60% and price to cash ratio as 17.14. Headwaters Incorporated (NYSE:HW) showed a weekly performance of 3.70%. Zacks cut shares of Headwaters Inc. (NYSE:HW) from a strong-buy rating to a sell rating in a research note.

Ambac Financial Group, Inc. (NASDAQ:AMBC) shares advanced 2.95% in last trading session and ended the day at $18.52. AMBC Gross Margin is value missing and its return on assets is 2.10%. Ambac Financial Group, Inc. (NASDAQ:AMBC) quarterly performance is -27.40%. Ambac Financial Group, Inc. (NASDAQ:AMBC) on 2 July, confirmed the full payment was made, relieving it of having to cover the payment to insured bondholders.

Leave a Reply

Your email address will not be published. Required fields are marked *